Standard Automatic Perimetry Humphrey Field Analyzer for Open-Angle Glaucoma

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Wills Eye Hospital, Philadelphia, PAOpen-Angle GlaucomaStandard Automatic Perimetry Humphrey Field Analyzer - DiagnosticTest
Eligibility
20 - 80
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a new way to do glaucoma testing at home, to see if it's feasible and if patients like it. They will also compare it to the current way of testing in the office, and monitor eye pressure at home.

Eligible Conditions
  • Open-Angle Glaucoma

Treatment Effectiveness

Study Objectives

2 Primary · 1 Secondary · Reporting Duration: 12 minutes each week for 104 weeks

Year 2
Change in Retinal Nerve Fiber Layer (RNFL) Thickness
Week 104
Change in Visual Field Mean Deviation with VisuALL
Year 2
Change in Intraocular Pressure with iCare
Year 2
Change in Visual Field Mean Deviation with Humphrey Field Analyzer

Trial Safety

Trial Design

1 Treatment Group

Moderate Glaucoma
1 of 1

Experimental Treatment

50 Total Participants · 1 Treatment Group

Primary Treatment: Standard Automatic Perimetry Humphrey Field Analyzer · No Placebo Group · N/A

Moderate GlaucomaExperimental Group · 4 Interventions: Standard Automatic Perimetry Humphrey Field Analyzer, visuALL H, iCare Home Tonometer, Spectralis Optical coherence tomography (OCT) · Intervention Types: DiagnosticTest, DiagnosticTest, DiagnosticTest, DiagnosticTest
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Standard Automatic Perimetry Humphrey Field Analyzer
2019
N/A
~80

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12 minutes each week for 104 weeks

Who is running the clinical trial?

Wills EyeLead Sponsor
77 Previous Clinical Trials
10,244 Total Patients Enrolled
M. Reza Razeghinejad, MDPrincipal InvestigatorWills Eye Hospital
1 Previous Clinical Trials
80 Total Patients Enrolled

Eligibility Criteria

Age 20 - 80 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Are there any remaining positions available in this research study?

"As of now, this research venture is actively searching for patients according to clinicaltrials.gov; the trial was initially posted on April 15th 2022 and most recently revised on April 25th 2022." - Anonymous Online Contributor

Unverified Answer

What is the total number of individuals participating in this research endeavor?

"Affirmative. Clinicaltrials.gov displays that this experiment, which was first announced on April 15th 2022, is actively recruiting participants. 50 individuals must be acquired from 1 medical facility to properly conduct the trial." - Anonymous Online Contributor

Unverified Answer

Does this research trial consider people aged 45 and over as viable participants?

"This clinical trial permits individuals aged 20 to 80 to partake. Conversely, 23 trials are available for participants younger than 18 whereas 200 studies are accessible for those above 65 years of age." - Anonymous Online Contributor

Unverified Answer

Who is eligible for enrollment in this experiment?

"In order to be eligible for this medical trial, potential candidates must have glaucoma of the open-angle variety and should fall within the age range between 20 to 80. This clinical study seeks a total of 50 participants." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.